Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Optimizing classification of diseases through language model analysis of symptoms
2024 Standout
Works of S. Boselli being referenced
Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors
2011
Combinations of the immunocytokine F16-IL2 with doxorubicin or with paclitaxel investigated in phase Ib studies in patients with advanced solid tumors.
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S. Boselli | 129 | 102 | 16 | 143 | 20 | 356 | |
| M.C. Cox | 173 | 169 | 52 | 115 | 23 | 409 | |
| Monica Recine | 143 | 71 | 61 | 98 | 18 | 307 | |
| Ehab Husain | 131 | 54 | 34 | 49 | 24 | 377 | |
| Ayşe Durnalı | 149 | 144 | 17 | 62 | 24 | 309 | |
| Roberto Togni | 151 | 62 | 132 | 61 | 20 | 389 | |
| Nassir Habboubi | 212 | 69 | 15 | 56 | 21 | 320 | |
| Alexandre Rouquette | 199 | 107 | 54 | 114 | 28 | 408 | |
| Bérengère Dadone | 119 | 169 | 37 | 64 | 17 | 372 | |
| J. Jordi Rowe | 100 | 43 | 11 | 169 | 26 | 312 | |
| Clarence Eng | 126 | 78 | 31 | 54 | 16 | 334 |
All Works
Loading papers...